Downloads
-
Streamlined dPCR Workflow For Lentiviral Characterization
7/14/2025
Discover a streamlined dPCR-based workflow for precise lentiviral vector quantification to support safer, more consistent cell and gene therapies through accurate genome titer, VCN, and RCL assessment.
-
Optimized Urine Liquid Biopsy Workflow
7/14/2025
Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology.
-
Liquid Biopsy-Based Detection Of PIK3CA Mutations From cfDNA
7/14/2025
Discover how ultra-sensitive digital PCR workflows use an innovative system to enable precise detection of rare PIK3CA mutations in cfDNA and advance personalized cancer treatment.
-
Liquid Biopsy: Accelerate Your Circulating Biomarker Research
7/14/2025
Unlock the power of an advanced, non-invasive diagnostic tool transforming cancer detection that tackles key challenges, delivering faster, more accurate insights for precision medicine breakthroughs.
-
Unlocking miRNA Biomarkers With NGS And Digital PCR
7/14/2025
Discover how next-generation sequencing and digital PCR enable miRNA biomarker discovery and validation. Learn best practices for sample prep, data analysis, and assay design to advance RNA research.
-
Detect Ultra-Rare Variants In cfDNA From Liquid Biopsy Samples
7/14/2025
Liquid biopsy, powered by next-generation sequencing, is transforming precision oncology to offer real-time, non-invasive insights into tumor genetics, which revolutionizes how we monitor and manage cancer.
-
Quantifying Lentiviral Physical Titer
7/14/2025
Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.
-
Prepare For Successful Biomarker Profiling From Cell-Free DNA
7/14/2025
Discover how standardized preanalytical practices for cell-free DNA can enhance liquid biopsy accuracy, which enables reliable detection of genomic and epigenetic alterations for improved diagnostics.
-
De-Risking CHO Cell Line Development With Automation And Predictive Modeling
7/11/2025
Discover how high-throughput, single-cell technologies combined with machine learning and automation are transforming clone selection to accelerate timelines and improve accuracy in bioprocessing.
-
From Discovery To Delivery: Accelerating The Path Forward For Gene Therapies
7/11/2025
We caught up with Lexeo Therapeutics’ Manny Otero, Ph.D., and Sandi See Tai, MD, to explore strategies to advance gene therapies.